The Palico Private Equity Fund Marketplace
Adveq Opportunity is a private equity general partner firm headquartered in New York, NY, United States.
Biopharmaceutical company Second Genome closed a $42.6m Series B investment round led by Pfizer Venture Investment and Roche Venture Fund.
Adveq has promoted Farah Buckley, Richard Damming, Matt Ma Chang, Daniel Rhoads, Nico Taverna and Ethan Vogelhut to Executive Directors.
Swiss PE fund of funds investor Adveq has promoted Gaia Arnaboldi and Anne-Juliane Knauer to executive directors.
Read more news concerning Adveq Opportunity
A sampling of Adveq Opportunity portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?